Us Bancorp \De\ Castle Biosciences Inc Transaction History
Us Bancorp \De\
- $75.6 Billion
- Q4 2024
A detailed history of Us Bancorp \De\ transactions in Castle Biosciences Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 1,202 shares of CSTL stock, worth $23,186. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,202
Previous 4,615
73.95%
Holding current value
$23,186
Previous $131,000
75.57%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CSTL
# of Institutions
210Shares Held
26.6MCall Options Held
128KPut Options Held
35.4K-
Black Rock Inc. New York, NY3.04MShares$58.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$35.3 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.8MShares$34.6 Million0.24% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.44MShares$27.7 Million0.02% of portfolio
-
Dimensional Fund Advisors LP Austin, TX999KShares$19.3 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $507M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...